Log inSign up
AAOIFI No. 21 screening

Is RGC halal?

Regencell Bioscience Holdings L

Halal

Regencell Bioscience Holdings L passed every check under AAOIFI Shariah standard No. 21: no prohibited business activity, and all three financial ratios are within limits.

Checked: 28 October 2026

Exchange

NASDAQ

Price

7.57

Day

+1.47%

Market cap

$3.70B

Industry

Drug Manufacturers - Specialty & Generic

Sector

Healthcare

What the company does

Regencell Bioscience (Hong Kong) develops traditional-Chinese-medicine treatments for ADHD and autism (10 employees). Almost no revenue; the market cap far exceeds the business.

What was checked

The AAOIFI standard has four steps: business activity first, then three financial ratios. Fail one and the stock is not halal.

  • Business activity

    No prohibited activity

  • Interest-bearing debt / market cap

    limit 30%

    Interest-bearing debt $0 ÷ 36-month average market cap $3.89B = 0.0%

    0.0%

    Pass

  • Cash & investments / market cap

    limit 30%

    Cash + interest-bearing securities $14.19M ÷ 36-month average market cap $3.89B = 0.4%

    0.4%

    Pass

  • Non-compliant income / total revenue

    limit 5%

    —

    No data

Figures from the company's filings (2026-06-30), USD. Market cap is a 36-month average (the S&P Shariah index approach), so a one-day price move does not flip the verdict. Today's market cap: $3.70B.

For information (AAOIFI 3/1 note): cash + receivables are 96.6% of total assets (2026-06-30). AAOIFI recommends tangible assets of at least one third — this figure does not affect the verdict, and other major screeners do not apply it either.

In the lists

In the S&P 500
Not in the S&P 500
Among halal stocks
0.01% · #639 of 1412

Halal stocks in the same industry

The largest halal stocks in Drug Manufacturers - Specialty & Generic — for comparison.

Related articles

Halal is the first question. The second: when to enter?

Our scanner watches 1412 halal stocks around the clock and fires a signal with entry, TP and SL when a technical setup completes. The full signal history — with outcomes — is public.

This is neither investment advice nor a fatwa. Screening is based on public financial statements and AAOIFI standard No. 21; data may lag. For a personal decision consult your own scholar.